The bookrunners for the IPO are Dexion Capital and Oriel Securities. The deal — for which a prospectus is planned for mid-March with listing in April — has been structured with several discount control and transparency features protecting investors from the shares trading below net asset value.
It ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
